SCHEMBL1705299

SCHEMBL1705299

c1cncc(CN[C@H]2CC[C@@H](Oc3ccc4cnccc4c3)CC2)c1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
KDM4E B2RXH2 2/20 0.54
PKM P14618 1/20 0.54
ROCK1 Q13464 3/20 0.53
ROCK2 O75116 1/20 0.53
IKBKB O14920 1/20 0.50
PRKCZ Q05513 1/20 0.49
VCP P55072 2/20 0.42
HRH3 Q9Y5N1 2/20 0.41
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
NAMPT P43490 1/20 0.40
KDM1A O60341 2/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1705680 1.00 ALDH1A1 (0.54) ALDH1A1KDM4EPKMROCK1ROCK2
SCHEMBL1705684 0.87 IKBKB (0.51) ALDH1A1KDM4EPKMROCK1ROCK2
SCHEMBL1705023 0.87 ROCK1 (0.49) ALDH1A1KDM4EPKMROCK1ROCK2
SCHEMBL1705022 0.87 ROCK1 (0.49) ALDH1A1KDM4EPKMROCK1ROCK2
SCHEMBL1705674 0.86 ROCK1 (0.53) ALDH1A1KDM4EPKMROCK1ROCK2
SCHEMBL1705070 0.86 ROCK1 (0.53) ALDH1A1KDM4EPKMROCK1ROCK2
SCHEMBL1705071 0.86 ROCK1 (0.53) ALDH1A1KDM4EPKMROCK1ROCK2
SCHEMBL1705839 0.85 ROCK1 (0.49) ALDH1A1ROCK1ROCK2IKBKBPRKCZ
SCHEMBL1705073 0.85 ROCK2 (0.49) ALDH1A1KDM4EPKMROCK1ROCK2
SCHEMBL1705117 0.84 ALDH1A1 (0.51) ALDH1A1KDM4EPKMROCK1ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8710228-B2 Cycloalkylamine substituted isoquinoline derivatives SANOFI (FR) 2014-04-29 US claimed
EP-2125746-B1 CYCLOALKYLAMINE SUBSTITUTED ISOQUINOLINE DERIVATIVES SANOFI SA (FR) 2012-04-18 EP claimed
US-8710228-B2 Cycloalkylamine substituted isoquinoline derivatives SANOFI (FR) 2014-04-29 US disclosed
US-8710228-B2 Cycloalkylamine substituted isoquinoline derivatives SANOFI (FR) 2014-04-29 US disclosed
US-8710228-B2 Cycloalkylamine substituted isoquinoline derivatives SANOFI (FR) 2014-04-29 US disclosed
EP-2125746-B1 CYCLOALKYLAMINE SUBSTITUTED ISOQUINOLINE DERIVATIVES SANOFI SA (FR) 2012-04-18 EP disclosed
EP-2125746-B1 CYCLOALKYLAMINE SUBSTITUTED ISOQUINOLINE DERIVATIVES SANOFI SA (FR) 2012-04-18 EP disclosed
US-20100081671-A1 Cycloalkylamine substituted isoquinoline derivatives SANOFI-AVENTIS (FR) 2010-04-01 US disclosed
US-20100081671-A1 Cycloalkylamine substituted isoquinoline derivatives SANOFI-AVENTIS (FR) 2010-04-01 US disclosed
US-20100081671-A1 Cycloalkylamine substituted isoquinoline derivatives SANOFI-AVENTIS (FR) 2010-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100081671-A1 Cycloalkylamine substituted isoquinoline derivatives MYLK2, MYLK, MYLK3 ALDH1A1 3715/4885KDM4E 2709/4885PKM 983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.